ROBERT JOHN MCDONALD, MD
Radiology at Sand Dollar Dr, Sanibel, FL
License number
Florida ME0051842
Category
Medical Practice
Type
Nuclear Medicine
License number
Florida ME51842
Category
Radiology
Type
Nuclear Radiology
Address
Address
821 Sand Dollar Dr, Sanibel, FL 33957
Phone
(239) 823-0057
(877) 826-0514 (Fax)
(877) 826-0514 (Fax)
Professional information
Dr. Robert Mcdonald, Orlando FL - MD (Doctor of Medicine)
Specialties:
Nuclear Medicine, Family Medicine
Address:
M D ANDERSON CANCER CTR-ORLAND
1400 S Orange Ave, Orlando 32806
(407) 648-5384 (Phone), (407) 649-6994 (Fax)
1400 S Orange Ave, Orlando 32806
(407) 648-3800 (Phone), (407) 425-5203 (Fax)
821 Sand Dollar Dr, Sanibel 33957
(239) 823-0057 (Phone), (877) 826-0514 (Fax)
1400 S Orange Ave, Orlando 32806
(407) 648-5384 (Phone), (407) 649-6994 (Fax)
1400 S Orange Ave, Orlando 32806
(407) 648-3800 (Phone), (407) 425-5203 (Fax)
821 Sand Dollar Dr, Sanibel 33957
(239) 823-0057 (Phone), (877) 826-0514 (Fax)
Languages:
English
Hospitals:
M D ANDERSON CANCER CTR-ORLAND
1400 S Orange Ave, Orlando 32806
821 Sand Dollar Dr, Sanibel 33957
1400 S Orange Ave, Orlando 32806
Gulf Coast Medical Center
13681 Doctors Way, Fort Myers 33912
1400 S Orange Ave, Orlando 32806
821 Sand Dollar Dr, Sanibel 33957
1400 S Orange Ave, Orlando 32806
Gulf Coast Medical Center
13681 Doctors Way, Fort Myers 33912
Education:
Medical School
Virginia Commonwealth University / Medical College of Virginia School of Medicine
Graduated: 1985
Brown University
Graduated: 1987
Uc Irvine Med Ctr/Long Beach Vamc
Graduated: 1991
Virginia Commonwealth University / Medical College of Virginia School of Medicine
Graduated: 1985
Brown University
Graduated: 1987
Uc Irvine Med Ctr/Long Beach Vamc
Graduated: 1991
Systems And Methods For Rf-Induced Hyperthermia Using Biological Cells And Nanoparticles As Rf Enhancer Carriers
US Patent:
2005025, Nov 10, 2005
Filed:
Feb 3, 2005
Appl. No.:
11/050481
Inventors:
John Kanzius - Erie PA, US
William Steinbrink - Erie PA, US
Robert McDonald - Sanibel FL, US
Michael Keating - Houston TX, US
William Steinbrink - Erie PA, US
Robert McDonald - Sanibel FL, US
Michael Keating - Houston TX, US
International Classification:
A61F002/00
US Classification:
607101000
Abstract:
A method of inducing hyperthermia in at least a portion of a target area—e.g., a tumor or a portion of a tumor or targeted cancerous cells—is provided. Targeted RF absorption enhancers, e.g., tumor infiltrating lymphocytes (TILs) containing RF absorbing particles, are introduced into a patient. These targeted RF absorption enhancers will target certain cells in the target areas and enhance the effect of a hyperthermia generating RF signal directed toward the target area. The targeted RF absorption enhancers may, in a manner of speaking, add one or more RF absorption frequencies to cells in the target area, which will permit a hyperthermia generating RF signal at that frequency or frequencies to heat the targeted cells.
Systems And Methods For Combined Rf-Induced Hyperthermia And Radioimmunotherapy
US Patent:
7627381, Dec 1, 2009
Filed:
Feb 3, 2005
Appl. No.:
11/050478
Inventors:
John Kanzius - Erie PA, US
William Harry Steinbrink - Erie PA, US
Robert J. McDonald - Sanibel FL, US
Michael J. Keating - Houston TX, US
William Harry Steinbrink - Erie PA, US
Robert J. McDonald - Sanibel FL, US
Michael J. Keating - Houston TX, US
Assignee:
Therm Med, LLC - Erie PA
International Classification:
A61F 2/00
US Classification:
607101
Abstract:
A combined radiotherapy and hyperthermia therapy is provided, including inducing hyperthermia in at least a portion of a target area—e. g. , a tumor or a portion of a tumor or targeted cancerous cells—is provided. Biomolecules labeled with at least one radionuclide suitable for radiotherapy are provided and introduced into a patient; targeted RF absorption enhancers are provided and introduced into a patient; and a hyperthermia generating RF signal is directed via toward the target cells, thereby warming the radionuclide-labeled biomolecules and targeted RF absorption enhancers bound to target cells. The targeted RF absorption enhancers may, in a manner of speaking, add one or more RF absorption frequencies to cells in the target area, which will permit a hyperthermia generating RF signal at that frequency or frequencies to heat the targeted cells. Biomolecules labeled with at least one radionuclide suitable for radiotherapy may be used for both radiotherapy and as RF absorption enhancers for the hyperthermia generating RF signal.